NCT07687316 Mental Effort During Low Load Resistance Training in Older Adults
| NCT ID | NCT07687316 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kennesaw State University |
| Condition | Seniors |
| Study Type | INTERVENTIONAL |
| Enrollment | 75 participants |
| Start Date | 2026-06-06 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 75 participants in total. It began in 2026-06-06 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to determine the effect of maximal mental effort combined with low-intensity resistance training on strength and neuromuscular function in older adults. The main questions it aims to answer are: * Does low-intensity resistance training in combination with maximal mental effort increase strength more than low intensity resistance training alone? * Does low-intensity resistance training in combination with maximal mental effort improve neuromuscular function more than low intensity resistance training alone? Participants will be randomly assigned to 1 of 3 groups: * Low intensity resistance training * Low intensity resistance training with maximal mental effort * Control Researchers will compare groups to determine differences in changes in strength, neuromuscular function, and body composition.
Eligibility Criteria
Inclusion Criteria: * Body mass index between 18.5 - 33 kg·m2 * No structured physical activity in past 2 years * Any unstable condition contradicting exercise * Independently walk with or without assistive device * No significant cognitive impairment Exclusion Criteria: * Score of 22 or lower on Montreal Cognitive Assessment * Missing more than 3 training sessions (training groups only) * Pacemaker * Unstable angina * Symptomatic heart failure * Uncontrolled arrythmias * Uncontrolled hypertension (greater or equal to 160/90) * Myocardial infarction in the past 6 months * Uncontrolled type 2 diabetes * Type 1 diabetes * Severe or unstable pulmonary conditions, * Currently on supplemental oxygen therapy * Severe hearing loss or visual impairment * Alzheimer's Disease or significant cognitive impairment * Stroke in the past 6 months or ongoing stroke-induced motor impairment * Any neurological (e.g., Parkinson's) condition affecting motor control * Undergoing chemotherapy * Surgery in past 6 months * Musculoskeletal injury in the past 6 months * Terminal illness * Stage 3 or greater chronic kidney disease
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07687316 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, up to 85 Years, studying Seniors. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07687316 currently recruiting?
Yes, NCT07687316 is actively recruiting participants. Contact the research team at ghester4@kennesaw.edu for enrollment information.
Where is the NCT07687316 trial being conducted?
This trial is being conducted at Kennesaw, United States.
Who is sponsoring the NCT07687316 clinical trial?
NCT07687316 is sponsored by Kennesaw State University. The trial plans to enroll 75 participants.